CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...

CVS Health CEO David Joyner sees a way to create a more efficient healthcare professional network under the CVS umbrella.

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

Wall Street appears to like CVS (CVS) CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday.